Painkiller 'Nyloxin' is prepared from the venom of :

Question

Accepted Answer

The correct option is 2: Cobra

The painkiller 'Nyloxin' is a commercial pharmaceutical preparation whose active component is derived from the venom of the Cobra, specifically the Indian Cobra (*Naja naja*). This application of snake venom falls under the field of venomics and drug discovery, where toxic compounds are isolated, purified, and re-engineered for medical use. The purified neurotoxic peptide, sometimes referred to as cobratoxin, is the core analgesic agent. In its therapeutic, highly diluted form, this peptide interacts with the nervous system to block the transmission of pain signals without the addictive properties of traditional opioid medications. Nyloxin is marketed for the topical management of chronic pain conditions like nerve pain and arthritis, demonstrating a powerful example of how the unique biological activity of a potent venom can be harnessed and controlled for safe human benefit.

The incorrect option is 1: Pit Viper
Pit Vipers are members of the Viperidae family, a group of snakes whose venom is predominantly **hemotoxic** and **cytotoxic**. This type of venom primarily destroys red blood cells, disrupts the blood clotting mechanism, and causes severe tissue damage (necrosis) at the bite site. While many compounds from viper venoms are being researched, particularly for their anticoagulant properties—leading to drugs like eptifibatide—they do not possess the specific neurotoxic peptide that imparts the analgesic effect of Nyloxin. Therefore, the biochemical action of Pit Viper venom is fundamentally different, rendering it an incorrect source for this specific pain relief product.

The incorrect option is 3: Krait
Krait snakes (*Bungarus* species) produce one of the most potent venoms in the world, which is a powerful **neurotoxin** and shares the Elapidae family with the Cobra. Their venom contains $\alpha$-bungarotoxin, which is renowned for causing rapid, fatal paralysis by blocking the acetylcholine receptors at the nerve-muscle junction. Although both Cobra and Krait venoms are neurotoxic, they contain unique toxin peptides with different molecular structures and mechanisms. The specific analgesic compound used in the commercially produced Nyloxin has been definitively isolated and derived from *Naja naja* (Cobra) venom, not *Bungarus* venom, making Krait the incorrect source for this particular pharmaceutical.

The incorrect option is 4: Hydrophis
*Hydrophis* represents a genus of highly venomous sea snakes, and like other Elapids, their venom is primarily composed of fast-acting **neurotoxins** designed to quickly paralyze their aquatic prey. While all highly neurotoxic venoms interact with the nervous system, the chemical composition of sea snake venom is adapted to the aquatic environment and differs structurally from terrestrial snake venoms. The commercial production of Nyloxin is based on a specific, purified peptide from *Naja naja* (Cobra). Consequently, despite the similar class of venom (neurotoxin), *Hydrophis* venom is not the correct biological source for the active ingredient in the painkiller Nyloxin.